Anaphylaxis: Guidelines from the European Academy of Allergy and Clinical Immunology

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 69, Issue 8, 2014, Pages 1026-1045

  Muraro, A ^a   Roberts, G ^b,c,d   Worm, M ^e   Bilo M B ^f   Brockow, K ^g   Fernandez Rivas M ^h   Santos, A F ^i,j,k   Zolkipli, Z Q ^b,c,d   Bellou, A ^l   Beyer, K ^e   Bindslev Jensen, C ^m   Cardona, V ⁿ   Clark, A T ^o   Demoly, P ^p   Dubois, A E J ^q   Dunngalvin, A ^r   Eigenmann, P ^s   Halken, S ^m   Harada, L ^t   Lack, G ^i,j   Jutel, M ^u   Niggemann, B ^e   Rueff F ^v   Timmermans, F ^w   Vlieg Boerstra, B J ^x   Werfel, T ^y   Dhami, S ^z   Panesar, S ^z   Akdis, C A ^aa   Sheikh, A ^ab   more..

^a UNIVERSITY OF PADOVA   (Italy)

^b ST MARY S HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f OSPEDALI RIUNITI   (Italy)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h HOSPITAL CLÍNICO SAN CARLOS   (Spain)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j KING'S COLLEGE LONDON   (United Kingdom)

^k CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^l RENNES UNIVERSITY HOSPITAL   (France)

^m ODENSE UNIVERSITY HOSPITAL   (Denmark)

ⁿ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^o UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^p HÔPITAL ARNAUD DE VILLENEUVE   (France)

^q UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^r UNIVERSITY COLLEGE CORK   (Ireland)

^s GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^t Anaphylaxis Canada   (Canada)

^u WROCLAW MEDICAL UNIVERSITY   (Poland)

^v UNIVERSITY OF MUNICH   (Germany)

^w Nederlands Anafylaxis Netwerk European Anaphylaxis Taskforce   (Netherlands)

^x UNIVERSITY OF AMSTERDAM   (Netherlands)

^y HANNOVER MEDICAL SCHOOL   (Germany)

^z Evidence Based Health Care Ltd   (United Kingdom)

^aa UNIVERSITY OF ZURICH   (Switzerland)

^ab UNIVERSITY OF EDINBURGH   (United Kingdom)

more..

Author keywords

adolescents; adults; anaphylaxis; children; management

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCAGON; GLUCOCORTICOID; INFUSION FLUID; INSECT VENOM; OXYGEN; SNAKE VENOM ANTISERUM;

ALLERGIC REACTION; ANAPHYLAXIS; ARTICLE; AUTOINJECTOR; BODY POSTURE; CLINICAL IMMUNOLOGY; CLINICAL PRACTICE; CONFLICT OF INTEREST; DESENSITIZATION; DISEASE SEVERITY; EMERGENCY CARE; FLUID THERAPY; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; LONG TERM CARE; MEDICAL AUDIT; MEDICAL EDUCATION; MENTAL HEALTH; NUT ALLERGY; PATIENT MONITORING; PEER REVIEW; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SNAKEBITE; SYSTEMATIC REVIEW (TOPIC); VENOM IMMUNOTHERAPY; EMERGENCY HEALTH SERVICE; EUROPE;

ANAPHYLAXIS; EMERGENCY MEDICAL SERVICES; EUROPE; HUMANS;

EID: 84904069310     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12437     Document Type: Article

References (132)

1. Panesar SS, Javad S, De Silva D, Nwaru BI, Hickstein L, Muraro A, et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy 2013; 68: 1353-1361.
2. Dhami S, Panesar SS, Roberts G, Muraro A, Worm M, Bilò B, et al. Management of anaphylaxis: a systematic review. Allergy 2014; 69: 159-167.
3. Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G, et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy 2007; 62: 857-871.
4. Soar J, Perkins GD, Abbas G, Alfonzo A, Barelli A, Bierens JJLM, et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution. Resuscitation 2010; 81: 1400-1433.
5. Soar J, Pumphrey R, Cant A, Clarke S, Corbett A, Dawson P, et al. Emergency treatment of anaphylactic reactions-guidelines for healthcare providers. Resuscitation 2008; 77: 157-169.
6. Simons FER, Ardusso LRF, Bilo MB, El-Gamal YM, Ledford DK, Ring J, et al. World Allergy Organization guidelines for the assessment and management of anaphylaxis. J Allergy Clin Immunol 2011; 127: 587-593.
7. Johansson SGO, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832-836.
8. Agree Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003; 12: 18-23.
9. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Can Med Assoc J 2010; 182: E839-E842.
10. Panesar SS, Nwaru B, Hickstein L, Rader T, Hamadah H, Ali D, et al. The epidemiology of anaphylaxis in Europe: protocol for a systematic review. Clin Transl Allergy 2013; 3: 9.
11. Dhami S, Panesar SS, Rader T, Muraro A, Roberts G, Worm M, et al. The acute and long-term management of anaphylaxis: protocol for a systematic review. Clin Transl Allergy 2013; 3: 14.
12. Oxford Centre for Evidence-based Medicine. Levels of Evidence and Grades of Recommendation. 2013. http://www.cebm.net/index.aspx?o=1025. Last accessed 25 March 2013.
13. Simons FER, Ardusso LRF, Bilò MB, El-Gamal YM, Ledford DK, Ring J, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 2011; 4: 13-37.
14. Tanno LK, Ganem F, Demoly P, Toscano CM, Bierrenbach AL,. Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10. Allergy 2012; 67: 783-789.
15. Simons FER, Clark S, Camargo CA Jr,. Anaphylaxis in the community: learning from the survivors. J Allergy Clin Immunol 2009; 124: 301-306.
16. Moro Moro M, Tejedor Alonso MA, Esteban Hernandez J, Mugica Garcia MVM, Rosado Ingelmo A, Vila Albelda C,. Incidence of anaphylaxis and subtypes of anaphylaxis in a general hospital emergency department. J Investig Allergol Clin Immunol 2011; 21: 142-149.
17. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol 2006; 117: 391-397.
18. Sampson HA, Munoz-Furlong A, Bock SA, Schmitt C, Bass R, Chowdhury BA, et al. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 2005; 115: 584-591.
19. Harduar-Morano L, Simon MR, Watkins S, Blackmore C,. Algorithm for the diagnosis of anaphylaxis and its validation using population-based data on emergency department visits for anaphylaxis in Florida. J Allergy Clin Immunol 2010; 126: 98-104.
20. Campbell RL, Hagan JB, Manivannan V, Decker WW, Kanthala AR, Bellolio MF, et al. Evaluation of national institute of allergy and infectious diseases/food allergy and anaphylaxis network criteria for the diagnosis of anaphylaxis in emergency department patients. J Allergy Clin Immunol 2012; 129: 748-752.
21. de Silva IL, Mehr SS, Tey D, Tang MLK,. Paediatric anaphylaxis: a 5 year retrospective review. Allergy 2008; 63: 1071-1076.
22. Pumphrey RSH,. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30: 1144-1150.
23. Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS,. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol 2004; 113: 536-542.
24. Brown SGA,. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004; 114: 371-376.
25. Worm M, Edenharter G, Rueff F, Scherer K, Pfohler C, Mahler V, et al. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy 2012; 67: 691-698.
26. Simons FER, Ardusso LR, Bilo MB, Dimov V, Ebisawa M, El-Gamal YM, et al. 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol 2012; 12: 389-399.
27. Steele R, Camacho-Halili M, Rosenthal B, Davis-Lorton M, Aquino M, Fonacier L,. Anaphylaxis in the community setting: determining risk factors for admission. Ann Allergy Asthma Immunol 2012; 109: 133-136.
28. Hompes S, Kohli A, Nemat K, Scherer K, Lange L, Rueff F, et al. Provoking allergens and treatment of anaphylaxis in children and adolescents-data from the anaphylaxis registry of German-speaking countries. Pediatr Allergy Immunol 2011; 22: 568-574.
29. Braganza SC, Acworth JP, McKinnon DRL, Peake JE, Brown AFT,. Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child 2006; 91: 159-163.
30. Vetander M, Helander D, Flodstrom C, Ostblom E, Alfven T, Ly DH, et al. Anaphylaxis and reactions to foods in children- A population-based case study of emergency department visits. Clin Exp Allergy 2012; 42: 568-577.
31. Beyer K, Eckermann O, Hompes S, Grabenhenrich L, Worm M,. Anaphylaxis in an emergency setting-elicitors, therapy and incidence of severe allergic reactions. Allergy 2012; 67: 1451-1456.
32. Douglas DM, Sukenick E, Andrade WP, Brown JS,. Biphasic systemic anaphylaxis: an inpatient and outpatient study. J Allergy Clin Immunol 1994; 93: 977-985.
33. Ellis AK, Day JH,. Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients. Ann Allergy Asthma Immunol 2007; 98: 64-69.
34. Lee JM, Greenes DS,. Biphasic anaphylactic reactions in pediatrics. Pediatrics 2000; 106: 762-766.
35. Sampson HA,. Fatal food-induced anaphylaxis. Allergy 1998; 53: 125-130.
36. Lieberman P,. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 2005; 95: 217.
37. Mehr S, Liew WK, Tey D, Tang MLK,. Clinical predictors for biphasic reactions in children presenting with anaphylaxis. Clin Exp Allergy 2009; 39: 1390-1396.
38. Sala-Cunill A, Cardona V, Labrador-Horrillo M, Luengo O, Esteso O, Garriga T, et al. Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. Int Arch Allergy Immunol 2013; 160: 192-199.
39. Heinzerling L, Mari A, Bergmann KC, Bresciani M, Burbach G, Darsow U, et al. The skin prick test-European standards. Clin Transl Allergy 2013; 3: 3.
40. Cardona V, Luengo O, Garriga T, Labrador-Horrillo M, Sala-Cunill A, Izquierdo A, et al. Co-factor-enhanced food allergy. Allergy 2012; 67: 1316-1318.
41. Vlieg-Boerstra BJ, Duiverman EJ, Van Der Heide S, Bijleveld CMA, Kukler J, Dubois AEJ,. Should children with a history of anaphylaxis to foods undergo challenge testing? Clin Exp Allergy 2008; 38: 1935-1942.
42. Mertes PM, Alla F, Trechot P, Auroy Y, Jougla E, Groupe d'Etudes des Reactions Anaphylactoides P. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 2011; 128: 366-373.
43. Park HJ, Kim SH,. Factors associated with shock in anaphylaxis. Am J Emerg Med 2012; 30: 1674-1678.
44. Moneret-Vautrin DA,. Drugs as risk factors of food anaphylaxis in adults. [French] Facteurs de risque d'anaphylaxie alimentaire severe Role confirme de certaines classes de medicaments. Med Sci 2010; 26: 719-723.
45. Pumphrey RS, Gowland MH,. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol 2007; 119: 1018-1019.
46. Bock SA, Munoz-Furlong A, Sampson HA,. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007; 119: 1016-1018.
47. Calvani M, Cardinale F, Martelli A, Muraro A, Pucci N, Savino F, et al. Risk factors for severe pediatric food anaphylaxis in Italy. Pediatr Allergy Immunol 2011; 22: 813-819.
48. Gonzalez-Perez A, Aponte Z, Vidaurre CF, Rodriguez LAG,. Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. J Allergy Clin Immunol 2010; 125: 1098-1104.
49. Triggiani M, Patella V, Staiano RI, Granata F, Marone G,. Allergy and the cardiovascular system. Clin Exp Immunol 2008; 153: 7-11.
50. Wimazal F, Geissler P, Shnawa P, Sperr WR, Valent P,. Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience. Int Arch Allergy Immunol 2012; 157: 399-405.
51. Vander Leek TK, Liu AH, Stefanski K, Blacker B, Bock SA,. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Pediatr 2000; 137: 749-755.
52. Rueff F, Przybilla B, Bilo MB, Muller U, Scheipl F, Aberer W, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase- A study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 2009; 124: 1047-1054.
53. Hamilton MJ, Hornick JL, Akin C, Castells MC, Greenberger NJ,. Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations. J Allergy Clin Immunol 2011; 128: 147-152.
54. Bilo MB,. Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment. Allergy 2011; 66: 35-37.
55. Rueff F, Przybilla B, Dugas-Breit S,. Mastocytosis-clinical symptoms. Allergologie 2009; 32: 214-223.
56. Golden DB, Moffitt J, Nicklas RA, Freeman T, Graft DF, Reisman RE, et al. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol 2011; 127: 852-854.
57. Brockow K, Jofer C, Behrendt H, Ring J,. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008; 63: 226-232.
58. Shadick NA, Liang MH, Partridge AJ, Bingham C, Wright E, Fossel AH, et al. The natural history of exercise-induced anaphylaxis: survey results from a 10-year follow-up study. J Allergy Clin Immunol 1999; 104: 123-127.
59. Tewari A, Du TG, Lack G,. The difficulties of diagnosing food-dependent exercise-induced anaphylaxis in childhood- A case study and review. Pediatr Allergy Immunol 2006; 17: 157-160.
60. Aihara Y, Takahashi Y, Kotoyori T, Mitsuda T, Ito R, Aihara M, et al. Frequency of food-dependent, exercise-induced anaphylaxis in Japanese junior-high-school students. J Allergy Clin Immunol 2001; 108: 1035-1039.
61. Noimark L, Wales J, Du Toit G, Pastacaldi C, Haddad D, Gardner J, et al. The use of adrenaline autoinjectors by children and teenagers. Clin Exp Allergy 2012; 42: 284-292.
62. Westfall TC,. Adrenergic agonists and antagonists. In:, Chabner BA, Brunton LL, Knollmann BC, editors. Goodman and Gilman's the Pharmacological Basis of Therapeutics. New York: Mc Graw-Hill, 2006: 215-268.
63. Bock SA, Muoz-Furlong A, Sampson HA,. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107: 191-193.
64. Soreide EB,. Severe anaphylactic reactions outside hospital: etiology, symptoms and treatment. Acta Anaesthesiol Scand 1988; 32: 339-342.
65. Simons FER, Roberts JR, Gu X, Simons KJ,. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol 1998; 101: 33-37.
66. Simons FER, Gu X, Simons KJ,. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 2001; 108: 871-873.
67. Simons FER, Gu X, Silver NA, Simons KJ,. EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis. J Allergy Clin Immunol 2002; 109: 171-175.
68. Simons FER, Gu X, Johnston LM, Simons KJ,. Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis? J Allergy Clin Immunol 2000; 106: 1040-1044.
69. Simons FER, Sheikh A,. Anaphylaxis: the acute episode and beyond. BMJ 2013; 346: 602.
70. Simons FER, Schatz M,. Anaphylaxis during pregnancy. J Allergy Clin Immunol 2012; 130: 597-606.
71. Perel P, Roberts I,. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2012; 6: CD000567.
72. Nurmatov UB, Rhatigan E, Simons FER, Sheikh A,. H2 antihistamines for the treatment of anaphylaxis with and without shock: a systematic review. Ann Allergy Asthma Immunol 2014; 112: 126-131.
73. Runge JW, Martinez JC, Caravati EM, Williamson SG, Hartsell SC,. Histamine antagonists in the treatment of acute allergic reactions. Ann Emerg Med 1992; 21: 237-242.
74. Lin RY, Curry A, Pesola GR, Knight RJ, Lee HS, Bakalchuk L, et al. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med 2000; 36: 462-468.
75. Ellis BC, Brown SG,. Parenteral antihistamines cause hypotension in anaphylaxis. Emerg Med Australas 2013; 25: 92-93.
76. Thomas M,. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J 2005; 22: 272-273.
77. Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Beyer K, Bindslev-Jensen C, et al. EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy. Allergy, doi: 10.1111/all.12429.
78. Ewan PW, Clark AT,. Long-term prospective observational study of patients with peanut and nut allergy after participation in a management plan. Lancet 2001; 357: 111-115.
79. Ewan PW, Clark AT,. Efficacy of a management plan based on severity assessment in longitudinal and case-controlled studies of 747 children with nut allergy: proposal for good practice. Clin Exp Allergy 2005; 35: 751-756.
80. Kapoor S, Roberts G, Bynoe Y, Gaughan M, Habibi P, Lack G,. Influence of a multidisciplinary paediatric allergy clinic on parental knowledge and rate of subsequent allergic reactions. Allergy 2004; 59: 185-191.
81. Choo K, Sheikh A,. Action plans for the long-term management of anaphylaxis: systematic review of effectiveness. Clin Exp Allergy 2007; 37: 1090-1094.
82. Nurmatov U, Worth A, Sheikh A,. Anaphylaxis management plans for the acute and long-term management of anaphylaxis: a systematic review. J Allergy Clin Immunol 2008; 122: 353-361.
83. Uguz A, Lack G, Pumphrey R, Ewan P, Warner J, Dick J, et al. Allergic reactions in the community: a questionnaire survey of members of the anaphylaxis campaign. Clin Exp Allergy 2005; 35: 746-750.
84. Jarvinen KM, Sicherer SH, Sampson HA, Nowak-Wegrzyn A,. Use of multiple doses of epinephrine in food-induced anaphylaxis in children. J Allergy Clin Immunol 2008; 122: 133-138.
85. Manivannan V, Campbell RL, Bellolio MF, Stead LG, Li JT, Decker WW,. Factors associated with repeated use of epinephrine for the treatment of anaphylaxis. Ann Allergy Asthma Immunol 2009; 103: 395-400.
86. Rudders SA, Banerji A, Corel B, Clark S, Camargo CA Jr,. Multicenter study of repeat epinephrine treatments for food-related anaphylaxis. Pediatrics 2010; 125: e711-e718.
87. Johnson MJ, Foote KD, Moyses HE, Roberts G,. Practices in the prescription of adrenaline autoinjectors. Pediatr Allergy Immunol 2012; 23: 124-127.
88. Gold MS, Sainsbury R,. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). J Allergy Clin Immunol 2000; 106: 171-176.
89. Clark AT, Ewan PW,. Good prognosis, clinical features, and circumstances of peanut and tree nut reactions in children treated by a specialist allergy center. J Allergy Clin Immunol 2008; 122: 286-289.
90. Boyle RJ, Elremeli M, Hockenhull J, Cherry MG, Bulsara MK, Daniels M, et al. Venom immunotherapy for preventing allergic reactions to insect stings. Cochrane Database Syst Rev 2012; 10: CD008838.
91. Ross RN, Nelson HS, Finegold I,. Effectiveness of specific immunotherapy in the treatment of Hymenoptera venom hypersensitivity: a meta-analysis. Clin Ther 2000; 22: 351-358.
92. Watanabe AS, Fonseca LAM, Galvao CES, Kalil J, Castro FFM,. Specific immunotherapy using Hymenoptera venom: systematic review. Sao Paulo Med J 2010; 128: 30-37.
93. Hockenhull J, Elremeli M, Cherry MG, Mahon J, Lai M, Darroch J, et al. A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen for the treatment of bee and wasp venom allergy. Health Technol Assess 2012; 16: III-IV, 1.
94. Oude Elberink JNG, De Monchy JGR, Van Der Heide S, Guyatt GH, Dubois AEJ,. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom. J Allergy Clin Immunol 2002; 110: 174-182.
95. Oude Elberink JNG, van der Heide S, Guyatt GH, Dubois AEJ,. Analysis of the burden of treatment in patients receiving an EpiPen for yellow jacket anaphylaxis. J Allergy Clin Immuno 2006; 118: 699-704.
96. Rueff F, Bilo MB, Cichocka-Jarosz E, Muller U, Elberink HO, Sturm G,. Immunotherapy for Hymenoptera venom allergy: too expensive for European health care? Allergy 2013; 68: 407-408.
97. Golden DBK, Valentine MD, Kagey-Sobotka A, Lichtenstein LM,. Regimens of Hymenoptera venom immunotherapy. Ann Intern Med 1980; 92: 620-624.
98. Mosbech H, Muller U, Behalf of the Study Group. Side-effects of insect venom immunotherapy: results from an EAACI multicenter study. Allergy 2000; 55: 1005-1010.
99. Blumchen K, Ulbricht H, Staden U, Dobberstein K, Beschorner J, de Oliveira LCL, et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010; 126: 83-91.
100. Habib A,. Effect of pre-medication on early adverse reactions following antivenom use in snakebite. Drug-Safety 2011; 34: 869-880.
101. de Silva HA, Pathmeswaran A, Ranasinha CD, Jayamanne S, Samarakoon SB, Hittharage A, et al. Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial. PLoS Med 2011; 8: e1000435.
102. Gawarammana IB, Kularatne SA, Dissanayake WP, Kumarasiri RP, Senanayake N, Ariyasena H,. Parallel infusion of hydrocortisone +/- chlorpheniramine bolus injection to prevent acute adverse reactions to antivenom for snakebites. [Erratum appears in Med J Aust. 2004 Apr 19;180(8):428]. Med J Aust 2004; 180: 20-23.
103. Tramer MR, von Elm E, Loubeyre P, Hauser C,. Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review. BMJ 2006; 333: 675-681.
104. Brockow K, Ring J,. Anaphylaxis to radiographic contrast media. Curr Opin Allergy Clin Immunol 2011; 11: 326-331.
105. Mehl A, Wahn U, Niggemann B,. Anaphylactic reactions in children- A questionnaire-based survey in Germany. Allergy 2005; 60: 1440-1445.
106. Clark S, Bock SA, Gaeta TJ, Brenner BE, Cydulka RK, Camargo CA,. Multicenter study of emergency department visits for food allergies. J Allergy Clin Immunol 2004; 113: 347-352.
107. Grabenhenrich L, Hompes S, Gough H, Rueff F, Scherer K, Pfohler C, et al. Implementation of anaphylaxis management guidelines: a register-based study. PLoS ONE 2012; 7: e35778.
108. MacKenzie H, Roberts G, van Laar D, Dean T,. Teenagers' experiences of living with food hypersensitivity: a qualitative study. Pediatr Allergy Immunol 2010; 21: 595-602.
109. Monks H, Gowland MH, MacKenzie H, Erlewyn-Lajeunesse M, King R, Lucas JS, et al. How do teenagers manage their food allergies? Clin Exp Allergy 2010; 40: 1533-1540.
110. DunnGalvin A, Gaffney A, Hourihane JOB,. Developmental pathways in food allergy: a new theoretical framework. Allergy 2009; 64: 560-568.
111. Worth A, Regent L, Levy M, Ledford C, East M, Sheikh A,. Living with severe allergy: an Anaphylaxis Campaign national survey of young people. Clin Transl Allergy 2013; 3: 2.
112. Barnett J, Botting N, Gowland M, Lucas J,. The strategies that peanut and nut-allergic consumers employ to remain safe when travelling abroad. Clin Transl Allergy 2012; 2: 12.
113. Macadam C, Barnett J, Roberts G, Stiefel G, King R, Erlewyn-Lajeunesse M, et al. What factors affect the carriage of epinephrine auto-injectors by teenagers? Clin Transl Allergy 2012; 2: 3.
114. Kastner M, Harada L, Waserman S,. Gaps in anaphylaxis management at the level of physicians, patients, and the community: a systematic review of the literature. Allergy 2010; 65: 435-444.
115. Sicherer SH, Forman JA, Noone SA,. Use assessment of self-administered epinephrine among food-allergic children and pediatricians. Pediatrics 2000; 105: 359-362.
116. Guevara JP, Wolf FM, Grum CM, Clark NM,. Effects of educational interventions for self management of asthma in children and adolescents: systematic review and meta-analysis. BMJ 2003; 326: 1308-1309.
117. Staab D, Diepgen TL, Fartasch M, Kupfer J, Lob-Corzilius T, Ring J, et al. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ 2006; 332: 933-938.
118. Ducharme FM, Bhogal SK,. The role of written action plans in childhood asthma. Curr Opin Allergy Clin Immunol 2008; 8: 177-188.
119. Lagger G, Pataky Z, Golay A,. Efficacy of therapeutic patient education in chronic diseases and obesity. Patient Educ Couns 2010; 79: 283-286.
120. Powell H, Gibson PG,. Options for self-management education for adults with asthma. Cochrane Database Syst Rev 2003; 1: CD004107.
121. Sicherer SH, Vargas PA, Groetch ME, Christie L, Carlisle SK, Noone S, et al. Development and validation of educational materials for food allergy. J Pediatr 2012; 160: 651-656.
122. Segal N, Garty BZ, Hoffer V, Levy Y,. Effect of instruction on the ability to use a self-administered epinephrine injector. Isr Med Assoc J 2012; 14: 14-17.
123. Manassis K,. Managing anxiety related to anaphylaxis in childhood: a systematic review. J Allergy 2012, doi: 10.1155/2012/316296.
124. Akeson N, Worth A, Sheikh A,. The psychosocial impact of anaphylaxis on young people and their parents. Clin Exp Allergy 2007; 37: 1213-1220.
125. Vickers DW, Maynard L, Ewan PW,. Management of children with potential anaphylactic reactions in the community: a training package and proposal for good practice. Clin Exp Allergy 1997; 27: 898-903.
126. Patel BM, Bansal PJ, Tobin MC,. Management of anaphylaxis in child care centers: evaluation 6 and 12 months after an intervention program. Ann Allergy Asthma Immunol 2006; 97: 813-815.
127. Anagnostou K, Harrison B, Iles R, Nasser S,. Risk factors for childhood asthma deaths from the UK Eastern Region Confidential Enquiry 2001-2006. Prim Care Respir J 2012; 21: 71-77.
128. Hourihane JO, Kilburn SA, Dean P, Warner JO,. Clinical characteristics of peanut allergy. Clin Exp Allergy 1997; 27: 634-639.
129. Bonifazi F, Jutel M, Bilo BM, Birnbaum J, Muller U, Hypersensitivity EIGoIV. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005; 60: 1459-1470.
130. Krishna MT, Ewan PW, Diwakar L, Durham SR, Frew AJ, Leech SC, et al. Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines. Clin Exp Allergy 2011; 41: 1201-1220.
131. Sicherer SH, Simons FER,. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. J Allergy Clin Immunol 2005; 115: 575-583.
132. Papadopoulos N, Agache I, Bavbek S, Bilo B, Braido F, Cardona V, et al. Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy 2012; 2: 21.